U.S. Atopic Dermatitis Clinical Trials Market Size & Outlook
U.S. atopic dermatitis clinical trials market, 2018-2030 (US$M)
Related Markets
U.S. atopic dermatitis clinical trials market highlights
- The U.S. atopic dermatitis clinical trials market generated a revenue of USD 653.8 million in 2023 and is expected to reach USD 1,323.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, large molecules was the largest revenue generating molecule type in 2023.
- Large Molecules is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Atopic dermatitis clinical trials market data book summary
| Market revenue in 2023 | USD 653.8 million |
| Market revenue in 2030 | USD 1,323.9 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Large molecules |
| Fastest growing segment | Large Molecules |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small molecules, Large Molecules |
| Key market players worldwide | Charles River Laboratories International Inc, ReproCELL, Oncodesign, Novotech, Syneos Health |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.1% of the global atopic dermatitis clinical trials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. atopic dermatitis clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,323.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Atopic Dermatitis Clinical Trials Market Scope
Atopic Dermatitis Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. atopic dermatitis clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis clinical trials market will help companies and investors design strategic landscapes.
Large molecules was the largest segment with a revenue share of 53.27% in 2023. Horizon Databook has segmented the U.S. atopic dermatitis clinical trials market based on small molecules, large molecules covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. atopic dermatitis clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. atopic dermatitis clinical trials market databook
-
Our clientele includes a mix of atopic dermatitis clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. atopic dermatitis clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into U.S. atopic dermatitis clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. atopic dermatitis clinical trials market size, by molecule type, 2018-2030 (US$M)
U.S. Atopic Dermatitis Clinical Trials Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
